Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: A series of 1097 cases

Journal of Neurosurgery

Volumn 118, Issue 6, 2013, Pages 1157-1168

  Capelle, Laurent ^a,b   Fontaine, Denys ^a   Mandonnet, Emmanuel ^a   Taillandier, Luc ^b   Golmard, Jean Louis ^c   Bauchet, Luc ^a   Pallud, Johan ^d   Peruzzi, Philippe ^e   Baron, Marie Hélène ^f   Kujas, Michèle ^g   Guyotat, Jacques ^h   Guillevin, Remi ^c   Frenay, Marc ⁱ   Taillibert, Sophie ^b   Colin, Philippe ^j   Rigau, Valérie ^g   Vandenbo, Fanny ^k   Pinelli, Catherine ^l   Duffau, Hugues ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Department of Biostatistics ^*  (France)

^d CENTRE HOSPITALIER SAINTE ANNE   (France)

^e REIMS UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF BESANÇON   (France)

^g MONTPELLIER UNIVERSITY HOSPITAL   (France)

^h HOSPICES CIVILS DE LYON   (France)

ⁱ CENTRE ANTOINE LACASSAGNE   (France)

^j Polyclinique Courlancy   (France)

^k UNIVERSITY HOSPITAL OF NICE   (France)

^l UNIVERSITY HOSPITAL OF NANCY   (France)

more..

Author keywords

Glioma; Low grade; Oncology; Prognosis; Surgery; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84878737424     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.1.JNS121     Document Type: Article

References (72)

1. Afra D, Müller W, Benoist G, Schröder R: Supratentorial recurrences of gliomas. Results of reoperations on astrocytomas and oligodendrogliomas. Acta Neurochir (Wien) 43:217-227, 1978 (Pubitemid 9044864)
2. Ahmadi R, Dictus C, Hartmann C, Zurn O, Edler L, Hartmann M, et al: Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir (Wien) 151:1359-1365, 2009
3. Alvord EC Jr: Patterns of growth of gliomas. AJNR Am J Neuroradiol 16:1013-1017, 1995
4. Bartolomei JC, Christopher S, Vives K, Spencer DD, Piepmeier JM: Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity. J Neurooncol 34:79-84, 1997 (Pubitemid 27270253)
5. Bauchet L, Rigau V, Mathieu-Daudé H, Figarella-Branger D, Hugues D, Palusseau L, et al: French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol 84:189-199, 2007 (Pubitemid 47202129)
6. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, et al: Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923-929, 1999 (Pubitemid 29525456)
7. Bauman G, Pahapill P, Macdonald D, Fisher B, Leighton C, Cairncross G: Low grade glioma: a measuring radiographic response to radiotherapy. Can J Neurol Sci 26:18-22, 1999 (Pubitemid 29088319)
8. Baumert BG, Stupp R: Is there a place for radiotherapy in low-grade gliomas? Adv Tech Stand Neurosurg 35:159-182, 2010
9. Berger MS, Deliganis AV, Dobbins J, Keles GE: The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784-1791, 1994 (Pubitemid 24301834)
10. Brasil Caseiras G, Ciccarelli O, Altmann DR, Benton CE, Tozer DJ, Tofts PS, et al: Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology 253:505-512, 2009
11. Cavaliere R, Lopes MB, Schiff D: Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 4:760-770, 2005 (Pubitemid 41457292)
12. Celli P, Nofrone I, Palma L, Cantore G, Fortuna A: Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery 35:1018-1035, 1994 (Pubitemid 24371187)
13. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al: Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227-235, 2008 (Pubitemid 351213284)
14. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, et al: Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 109:817-824, 2008
15. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Nelson DF, et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 12:219-227, 1992
16. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, et al: Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria. J Neurooncol 34:61-78, 1997 (Pubitemid 27270252)
17. Desmurget M, Bonnetblanc F, Duffau H: Contrasting acute and slow-growing lesions: a new door to brain plasticity. Brain 130:898-914, 2007 (Pubitemid 47355582)
18. Duffau H: Intraoperative cortico-subcortical stimulations in surgery of low-grade gliomas. Expert Rev Neurother 5:473-485, 2005 (Pubitemid 41021054)
19. Duffau H: Surgery of low-grade gliomas: towards a 'functional neurooncology.' Curr Opin Oncol 21:543-549, 2009
20. Fried I: Management of low-grade gliomas: results of resections without electrocorticography. Clin Neurosurg 42:453-463, 1995
21. Hlaihel C, Guilloton L, Guyotat J, Streichenberger N, Honnorat J, Cotton F: Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. J Neurooncol 97:73-80, 2010
22. Johannesen TB, Langmark F, Lote K: Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 99:854-862, 2003 (Pubitemid 37314921)
23. Karak AK, Singh R, Tandon PN, Sarkar C: A comparative survival evaluation and assessment of interclassification concordance in adult supratentorial astrocytic tumors. Pathol Oncol Res 6:46-52, 2000 (Pubitemid 30262779)
24. Keles GE, Lamborn KR, Berger MS: Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735-745, 2001 (Pubitemid 33043344)
25. Keles GE, Lundin DA, Lamborn KR, Chang EF, Ojemann G, Berger MS: Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. J Neurosurg 100:369-375, 2004 (Pubitemid 38269062)
26. Kelly PJ: Surgical issues in the management of supratentorial low-grade gliomas. Clin Neurosurg 42:399-436, 1995
27. Kortmann RD: Radiotherapy in low-grade gliomas: pros. Semin Oncol 30 (6 Suppl 19):29-33, 2003
28. Kreth FW, Faist M, Grau S, Ostertag CB: Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors. Cancer 106:1372-1381, 2006 (Pubitemid 43363917)
29. Kros JM, Pieterman H, van Eden CG, Avezaat CJJ: Oligodendroglioma: the Rotterdam-Dijkzigt experience. Neurosurgery 34:959-966, 1994 (Pubitemid 24174234)
30. Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, Crinière E, Capelle L, Duffau H, et al: Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology 63:2360-2362, 2004 (Pubitemid 40024350)
31. Laws ER Jr: Resection of low-grade gliomas. J Neurosurg 95: 731-732, 2001 (Pubitemid 33043342)
32. Laws ER Jr, Taylor WF, Clifton MB, Okazaki H: Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 61:665-673, 1984 (Pubitemid 14009855)
33. Lebrun C, Fontaine D, Ramaioli A, Vandenbos F, Chanalet S, Lonjon M, et al: Long-term outcome of oligodendrogliomas. Neurology 62:1783-1787, 2004 (Pubitemid 38661735)
34. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, Mac-Donald D, et al: Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15:1294-1301, 1997 (Pubitemid 27167360)
35. Loiseau H, Bousquet P, Rivel J, Vital C, Kantor G, Rougier A, et al: [Supra-tentorial low-grade astrocytomas in adults. Prognostic factors and therapeutic indications. Apropos of a series of 141 patients.] Neurochirurgie 41:38-50, 1995 (Fr)
36. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, et al: Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129-3140, 1997 (Pubitemid 27377505)
37. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007 (Pubitemid 47103521)
38. Lunsford LD, Somaza S, Kondziolka D, Flickinger JC: Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J Neurosurg 82:523-529, 1995
39. Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, et al: Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53: 524-528, 2003 (Pubitemid 36373265)
40. Mandonnet E, Duffau H, Bauchet L: A new tool for grade II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation. J Neurooncol 106: 213-215, 2012
41. Mandonnet E, Pallud J, Clatz O, Taillandier L, Konukoglu E, Duffau H, et al: Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm. Neurosurg Rev 31:263-269, 2008
42. Mandonnet E, Pallud J, Fontaine D, Taillandier L, Bauchet L, Peruzzi P, et al: Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurg Rev 33:91-96, 2010
43. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, et al: Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63:700-708, 2008
44. Nikas DC, Bello L, Zamani AA, Black PM: Neurosurgical considerations in supratentorial low-grade gliomas: experience with 175 patients. Neurosurg Focus 4(4):e4, 1998
45. Olson JD, Riedel E, DeAngelis LM: Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442-1448, 2000 (Pubitemid 30210463)
46. Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R, et al: Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol 11: 176-182, 2009
47. Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, et al: Natural history of incidental World Health Organization grade II gliomas. Ann Neurol 68:727-733, 2010
48. Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D, et al: Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 60:380-383, 2006 (Pubitemid 44520241)
49. Peyre M, Cartalat-Carel S, Meyronet D, Ricard D, Jouvet A, Pallud J, et al: Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol 12:1078-1082, 2010
50. Piepmeier JM, Fried I, Makuch R: Low-grade astrocytomas may arise from different astrocyte lineages. Neurosurgery 33:627-632, 1993 (Pubitemid 23292754)
51. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20: 2076-2084, 2002 (Pubitemid 34408798)
52. Pouratian N, Schiff D: Management of low-grade glioma. Curr Neurol Neurosci Rep 10:224-231, 2010
53. Recht LD, Lew R, Smith TW: Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31:431-436, 1992
54. Rees JH: Low-grade gliomas in adults. Curr Opin Neurol 15:657-661, 2002 (Pubitemid 35471672)
55. Rees JH, Benton C, Watt H, Fox CI, Waldman A, Jäger HR, et al: Precise volume measurements of low-grade gliomas. Some surprising findings. J Neurol Neurosurg Psychiatry 75:518-519, 2004 (Abstract)
56. Ricard D, Kaloshi G, Amiel-Benouaich A, Lejeune J, Marie Y, Mandonnet E, et al: Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol 61:484-490, 2007 (Pubitemid 46878776)
57. Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G: Molecular diagnostics of gliomas: state of the art. Acta Neuropathol 120:567-584, 2010
58. Sanai N, Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753-764, 2008
59. Schiff D, Brown PD, Giannini C: Outcome in adult low-grade glioma: the impact of prognostic factors and treatment. Neurology 69:1366-1373, 2007 (Pubitemid 47482451)
60. Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, O'Neill BP, et al: Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol 11:437-445, 2009
61. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, et al: Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial lowgrade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267-2276, 2002 (Pubitemid 34441653)
62. Shaw EG, Berkey B, Coons SW, Brachman D, Buckner JC, Stelzer KJ, et al: Initial report of Radiation Therapy Oncology Group (RTOG) 9802: prospective studies in adult low-grade glioma (LGG). J Clin Oncol 24:1500, 2006
63. Shaw EG, Berkey B, Coons SW, Bullard D, Brachman D, Buckner JC, et al: Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg 109:835-841, 2008
64. Shaw EG, Scheithauer BW, O'Fallon JR, Davis DH: Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery 34:577-582, 1994 (Pubitemid 24100523)
65. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al: Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26: 1338-1345, 2008
66. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, et al: Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17:1124-1133, 2010
67. Soffietti R, Chiò A, Giordana MT, Vasario E, Schiffer D: Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery 24:686-692, 1989 (Pubitemid 19115923)
68. Sorensen AG, Patel S, Harmath C, Bridges S, Synnott J, Sievers A, et al: Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19:551-557, 2001 (Pubitemid 32112870)
69. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al: Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985-990, 2005 (Pubitemid 41323034)
70. (Erratum in Lancet 367:1818, 2006)
71. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C: Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64:581-587, 1998 (Pubitemid 28204142)
72. Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH, Twijnstra A: Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 2:395-403, 2003 (Pubitemid 36793931)